Microbot Medical

MBOT · NASDAQ

$0.9475−$0.0053 (−0.56%)TodayMarket closed · Oct 20, 7:49 PM ET

Prev close $0.9528

Latest news

Press releaseOct 20, 8:30 AM ETGlobe Newswire
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
NewsOct 6, 8:35 AM ET
Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel
Press releaseOct 6, 8:30 AM ETGlobe Newswire
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
Press releaseSep 25, 5:30 PM ETGlobe Newswire
Microbot Medical® Highlights Growth Strategy
Press releaseAug 11, 9:20 AM ETGlobe Newswire
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
Press releaseJul 21, 8:30 AM ETGlobe Newswire
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
Press releaseJul 7, 8:30 AM ETGlobe Newswire
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
Press releaseJun 30, 8:30 AM ETGlobe Newswire
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
Press releaseJun 25, 8:30 AM ETGlobe Newswire
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Press releaseJun 23, 8:30 AM ETGlobe Newswire
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
Press releaseMar 27, 10:15 AM ETPRNewswire
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
Press releaseFeb 24, 8:30 AM ETGlobe Newswire
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
Press releaseFeb 12, 8:30 AM ETGlobe Newswire
Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
NewsFeb 10, 7:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsFeb 10, 4:45 AM ETAvi Kapoor
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Press releaseFeb 5, 8:30 AM ETGlobe Newswire
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
Press releaseJan 12, 8:30 AM ETGlobe Newswire
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
Press releaseNov 26, 8:30 AM ETGlobe Newswire
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
Press releaseNov 5, 8:30 AM ETGlobe Newswire
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
NewsOct 1, 9:14 AM ET
Microbot Medical Announces That The Japanese Patent Office Has Granted The Company Its First Patent In Japan, Covering The Core LIBERTY System Technology
Press releaseOct 1, 9:00 AM ETGlobe Newswire
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
NewsSep 11, 8:08 AM ETAvi Kapoor
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Press releaseApr 15, 9:00 AM ETGlobe Newswire
Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry
Press releaseFeb 4, 8:30 AM ETGlobe Newswire
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
NewsJan 7, 12:42 PM ETThe Arora Report
ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO
NewsJan 6, 6:24 AM ETRishabh Mishra
US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025
NewsJan 6, 5:38 AM ETAvi Kapoor
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Press releaseDec 3, 8:45 AM ETGlobe Newswire
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio

Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel

Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel

Microbot Medical® Highlights Growth Strategy

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical Announces That The Japanese Patent Office Has Granted The Company Its First Patent In Japan, Covering The Core LIBERTY System Technology

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO

US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025

Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket

Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected